Literature DB >> 9157159

Rapid screening method for identification of cholera toxin-producing Vibrio cholerae O1 and O139.

R Osawa1, T Okitsu, S Sata, S Yamai.   

Abstract

A novel method of identifying cholera enterotoxin (CT)-producing Vibrio cholerae serogroups O1 and O139 was developed. The method uses degradation of NAD as a specific biochemical marker for the CT-producing strains. The substrate NAD at a concentration of 100 mumol/liter was markedly degraded when it was incubated at 37 degrees C for 2 h with the CT-producing stains at a final cell density equivalent to that of a twofold dilution of a McFarland no. 1 standard. NAD degradation was monitored by an enzyme-amplified color development assay. Subsequent tests conducted with a total of 119 strains of V. cholerae, including both clinical and environmental isolates, confirmed a significant correlation between NAD degradation and CT production for all V. cholerae strains belonging to serogroups O1 and O139. Since 2 of 11 non-O1, non-O139 V. cholerae strains not carrying the CT gene degraded NAD, serotyping of the strains prior to the test is recommended.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9157159      PMCID: PMC229707          DOI: 10.1128/jcm.35.4.951-953.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  [Detection of toxigenic Vibrio cholerae O1 using polymerase chain reaction for amplifying the cholera enterotoxin gene].

Authors:  K Kobayashi; K Seto; S Akasaka; M Makino
Journal:  Kansenshogaku Zasshi       Date:  1990-10

Review 2.  Activation of adenylate cyclase by choleragen.

Authors:  J Moss; M Vaughan
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

3.  ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase.

Authors:  D M Gill; R Meren
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

4.  Outbreak of Vibrio cholerae non-O1 in India and Bangladesh.

Authors:  M K Bhattacharya; S K Bhattacharya; S Garg; P K Saha; D Dutta; G B Nair; B C Deb; K P Das
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

Review 5.  Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp.

Authors:  J M Janda; C Powers; R G Bryant; S L Abbott
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

6.  Cholera enterotoxin production in Vibrio cholerae O1 strains isolated from the environment and from humans in Japan.

Authors:  A Minami; S Hashimoto; H Abe; M Arita; T Taniguchi; T Honda; T Miwatani; M Nishibuchi
Journal:  Appl Environ Microbiol       Date:  1991-08       Impact factor: 4.792

7.  Enzyme amplified immunoassay: a novel technique applied to direct detection of Chlamydia trachomatis in clinical specimens.

Authors:  S F Pugh; R C Slack; E O Caul; I D Paul; P N Appleton; S Gatley
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

8.  Development and testing of a nonradioactive DNA oligonucleotide probe that is specific for Vibrio cholerae cholera toxin.

Authors:  A C Wright; Y Guo; J A Johnson; J P Nataro; J G Morris
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

9.  Use of polymerase chain reaction for detection of toxigenic Vibrio cholerae O1 strains from the Latin American cholera epidemic.

Authors:  P I Fields; T Popovic; K Wachsmuth; O Olsvik
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

10.  Botulinum ADP-ribosyltransferase C3. Purification of the enzyme and characterization of the ADP-ribosylation reaction in platelet membranes.

Authors:  K Aktories; S Rösener; U Blaschke; G S Chhatwal
Journal:  Eur J Biochem       Date:  1988-03-01
  10 in total
  1 in total

1.  Characteristics and genetic diversity of bioluminescent Shewanella woodyi strains isolated from the Gulf of Izmir, Turkey.

Authors:  Esra Ersoy Omeroglu; Ismail Karaboz; Mert Sudagidan
Journal:  Folia Microbiol (Praha)       Date:  2013-07-31       Impact factor: 2.099

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.